- Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. Andreeff, M., Stone, R., Michaeli, J., Young, C.W., Tong, W.P., Sogoloff, H., Ervin, T., Kufe, D., Rifkind, R.A., Marks, P.A. Blood (1992)